MXCT Stock Price, Chart, Stats & News

MaxCyte, Inc. is a global life sciences enterprise dedicated to the identification, advancement, and commercialization of cutting-edge cell therapies. Its product portfolio encompasses a suite of ExPERT electroporation instruments: the ATx, designed for static electroporation in small to medium-scale cell transfection; the STx, a flow electroporation system facilitating protein creation, drug discovery, and the expression of therapeutic targets for cell-based analyses; the GTx, another flow electroporation solution, but tailored for extensive transfection in therapeutic contexts; and the VLx, engineered for exceptionally high-volume cell manipulation. Furthermore, the company supplies disposable processing assemblies (PAs) essential for cell processing and electroporation, alongside complementary accessories such as electroporation buffer solutions and software protocols.